Open access
Jul 2026
Durability and Breadth of Neutralizing Antibodies Against SARS-CoV-2 Variants Following XBB.1.5 Vaccination in a Multiply Exposed Cohort.
The observed waning of cross-neutralizing antibodies against emerging variants underscores the challenge of maintaining durable protection and supports the need for continued monitoring of antibody responses to guide evidence-based updates to COVID-19 vaccines.
Wei Wang, E. Goguet, Sabrina Lusvarghi et al.
· Open Forum Infectious Diseas... · 0 citations